Search

Your search keyword '"Van Hulle, Carol A."' showing total 626 results

Search Constraints

Start Over You searched for: Author "Van Hulle, Carol A." Remove constraint Author: "Van Hulle, Carol A."
626 results on '"Van Hulle, Carol A."'

Search Results

3. Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status

5. Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment

7. Risk Factors and Child Outcomes Associated with Short and Long Interpregnancy Intervals

8. CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges

10. Longitudinal trajectories of myelin loss in the context of Alzhiemer’s disease biomarkers, glial activation, and APOE4

11. The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevance

12. “By Any Means Necessary”: Understanding the willingness of African‐American and American Indian/Alaska Native communities to engage in genetic and biomarker research: The UBIGR Study

13. An Update on the Building Bridges Study: Examining the effects of two interventions on trust in medical researchers and research attitudes among African American participants

14. Associations of physical activity with cerebrospinal fluid biomarkers of neurodegeneration, neuroinflammation, and Alzheimer’s disease

15. Apathy, cognition and beta amyloid in African Americans in the AA‐FAIM cohort

16. Relationship between APOE risk score and myelin in Alzheimer’s disease

17. Connected speech efficiency and lexical diversity are associated with PET amyloid and tau in a cognitively unimpaired sample

18. Social support, plasma amyloid, and cognitive function: Findings on cognitive resilience from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study

20. Intra‐ and post‐procedural lumbar puncture symptoms in a sample of Black/African American, American Indian/Alaska Native, and White middle age older adults

21. Two novel cerebrospinal fluid markers for vascular injury are associated with CSF markers of AD, neurodegeneration, and gliosis

22. Measuring longitudinal cognition: Individual tests versus composites

23. Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.

26. CSF metabolites associated with biomarkers of Alzheimer’s disease pathology

27. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals

28. Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA‐FAIM cohort

30. Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.

33. Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups

34. Is Parental Knowledge of their Adolescent Offspring’s Whereabouts and Peer Associations Spuriously Associated with Offspring Delinquency?

35. Temperament and Parenting during the First Year of Life Predict Future Child Conduct Problems

38. CSF metabolites associated with biomarkers of Alzheimer's disease pathology.

39. Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.

40. Liver-Specific Polygenic Risk Score Is Associated with Alzheimer’s Disease Diagnosis

42. Associations between Recall of Proper Names in Story Recall and CSF Amyloid and Tau in a Cognitively Unimpaired Sample

43. An examination of baseline plasma Aβ42/40 and intra‐individual cognitive variability (IICV) associations with longitudinal cognitive change in a Black Cohort: Data from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study

44. Associations between semantic memory for proper names in story recall and CSF amyloid and tau in a cognitively unimpaired sample

47. Trajectories of plasma Aβ42/40 among African Americans: Preliminary results from the African American Fighting Alzheimer’s in Midlife (AA‐FAIM) study

48. Diabetes is related to cognition but not plasma amyloid‐β 42/40 in an African American cohort

49. Plasma Aβ42/40 and PET amyloid associations among late‐middle‐aged African Americans: Preliminary results from the AA‐FAIM study

50. Relationships between psychosocial stress, cerebrospinal fluid markers of Alzheimer’s disease, and cognitive function in middle‐aged and older adults

Catalog

Books, media, physical & digital resources